Bone-modifying agents for bone metastasis in patients with breast cancer
The bone is the most common location of breast cancer metastasis. Bone metastasis causes pain and skeletal-related events (SREs), and affects the quality of life and survival of breast cancer patients. Bone-modifying agents, including bisphosphonates and denosumab, reduce the risk of SREs in these p...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kosin University College of Medicine
2024-06-01
|
| Series: | Kosin Medical Journal |
| Subjects: | |
| Online Access: | http://kosinmedj.org/upload/pdf/kmj-24-121.pdf |